Spineart is proud to announce the launch of its upgraded, and now single-use, TEKTONA®2 Vertebral Fracture Reduction System, featuring enhanced ergonomics and usability.
Aligned with the company’s goal of transforming spine surgery for patients, surgeons, and hospitals; Spineart has developed a minimally invasive technology that enables a targeted, controlled, and multidirectional reduction of the vertebral compression fracture with a fully repositionable instrument.
Combined with TEKTONA® HV Cement, TEKTONA®2 preserves the trabecular structure, while enabling a precise and efficient treatment of the fracture.
To learn more about this differentiated technology, please visit (spineart.com/fr/products/).
TEKTONA®2 is not FDA Approved.
(Visited 37 times, 7 visits today)